For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
- Mechanism
- Curator reviewed
Dromostanolone is a synthetic androgenic anabolic steroid and is approximately 5 times as potent as natural methyltestosterone. Like testosterone and other androgenic hormones, dromostanolone binds to the androgen receptor. This causes downstream genetic transcriptional changes. This ultimately causes retention of nitrogen, potassium, and phosphorus; increases protein anabolism; and decreases amino acid catabolism. The antitumour activity of dromostanolone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.
- Primary indication
- For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.Curator reviewed
- Formula / weight
- C23H36O3 · 360.538 g/mol (avg)
- Also known as
- 2M-DHTP · 2MDTP · Blackburn Compound · Dromostanolone propionate · Emdisterone
- Code names
- Re 346 · RS 1567
Resolves to
NOTIQUSPUUHHEH-UXOVVSIBSA-NSMILES[H][C@@]12CC[C@H](OC(=O)CC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)[C@H](C)C[C@]12CWhat you can answer from here — as of June 15, 2026
Which drugs share a target with Drostanolone propionate, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account